Security key
405024100
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)
CUSIP: 405024100
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common stock, $.01 par value per share
- Total 13F shares
- 51,775,808
- Total 13F value
- $3,833,648,345
- Share change
- -439,104
- Put/Call ratio
- 137%
- SEC-reported price per share
- $74.03
- Number of holders
- 260
- Value change
- -$28,085,090
- Number of buys
- 128
- Number of sells
- 120
- Shares outstanding
- 46,498,422
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
260
Top holders
10
HAE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
Broader feeds
Reporting periods
Holder history for CUSIP 405024100
Recent filing periods:
Ownership snapshot
Top reported holders of HAE - HAEMONETICS CORP - Common stock, $.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Comparable ownership
Top 5
Capital Research Global Investors
14%
WELLINGTON MANAGEMENT GROUP LLP
12%
BlackRock Finance, Inc.
12%
VANGUARD GROUP INC
11%
Neuberger Berman Group LLC
8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
14%
|
$409,424,000
6,281,436 shares
|
— | 30 Jun 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
12%
|
$367,491,000
5,638,084 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
12%
|
$363,993,000
5,584,435 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
11%
|
$327,340,000
5,022,082 shares
|
— | 30 Jun 2022 |
| Neuberger Berman Group LLC |
13F
Company
|
8%
|
$242,426,000
3,718,844 shares
|
— | 30 Jun 2022 |
| STATE STREET CORP |
13F
Company
|
3.6%
|
$108,819,000
1,669,517 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
260
Shares
51,775,808
Rows available
260
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
229
Q3 2022 holders
260
Holder diff
31
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend